D-0828-2022 Class II Terminated

Recalled by Olympia Compounding Pharmacy Dba Olympia Pharmacy — Orlando, FL

FDA drug recall D-0828-2022 was initiated by Olympia Compounding Pharmacy Dba Olympia Pharmacy on Apr 4, 2022 and is designated Class II. Reason for recall: Failed Reconstitution time The recall status is terminated (terminated Jun 17, 2024).

Recall Details

Product Type
Drugs
Report Date
May 4, 2022
Initiation Date
Apr 4, 2022
Termination Date
Jun 17, 2024
Voluntary/Mandated
Voluntary: Firm initiated

Product Description

NAD+ Nicotinamide Adenine Dinucleotide Lyophilized powder for reconstitution, Multi-Dose 500 mg Per Vial, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0083-00

Reason for Recall

Failed Reconstitution time

Distribution Pattern

Distributed Nationwide in the USA

Code Information

Lot: F41116 BUD: 6/16/2022,

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0828-2022
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 26, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.